{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "17362034", "DateCompleted": {"Year": "2007", "Month": "08", "Day": "09"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2007", "Month": "03", "Day": "16"}], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0893-228X", "JournalIssue": {"Volume": "20", "Issue": "4", "PubDate": {"Year": "2007", "Month": "Apr"}}, "Title": "Chemical research in toxicology", "ISOAbbreviation": "Chem Res Toxicol"}, "ArticleTitle": "Botanical dietary supplements gone bad.", "Pagination": {"StartPage": "586", "EndPage": "590", "MedlinePgn": "586-90"}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, USA."}], "Identifier": [], "LastName": "Dietz", "ForeName": "Birgit", "Initials": "B"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Bolton", "ForeName": "Judy L", "Initials": "JL"}], "GrantList": [{"GrantID": "P50 AT000155", "Acronym": "AT", "Agency": "NCCIH NIH HHS", "Country": "United States"}, {"GrantID": "P50 AT000155-010002", "Acronym": "AT", "Agency": "NCCIH NIH HHS", "Country": "United States"}, {"GrantID": "P50 AT00155", "Acronym": "AT", "Agency": "NCCIH NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Chem Res Toxicol", "NlmUniqueID": "8807448", "ISSNLinking": "0893-228X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Oils"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Dietary Supplements"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Oils"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Bent S, Ko R. Commonly used herbal medicines in the United States: a review. Am. J. Med. 2004;116:478\u2013485. see comment.", "ArticleIdList": ["15047038"]}, {"Citation": "Schilter B, Andersson C, Anton R, Constable A, Kleiner J, O\u2019Brien J, Renwick AG, Korver O, Smit F, Walker R, Natural Toxin Task Force of the European Branch of the International Life Sciences, I Guidance for the safety assessment of botanicals and botanical preparations for use in food and food supplements. Food Chem. Toxicol. 2003;41:1625\u20131649.", "ArticleIdList": ["14563389"]}, {"Citation": "Timbo BB, Ross MP, McCarthy PV, Lin C-TJ. Dietary Supplements in a National Survey: Prevalence of Use and Reports of Adverse Events. J. Am. Diet. Assoc. 2006;106:1966\u20131974.", "ArticleIdList": ["17126626"]}, {"Citation": "Molinari M, Watt KDS, Kruszyna T, Nelson R, Walsh M, Huang WY, Nashan B, Peltekian K. Acute Liver Failure Induced by Green Tea Extracts: Case Report and Review of the Literature. Liver Transpl. 2006;12:1892\u20131895.", "ArticleIdList": ["17133573"]}, {"Citation": "Anke J, Ramzan I. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.) J. Ethnopharmacol. 2004;93:153\u2013160.", "ArticleIdList": ["15234747"]}, {"Citation": "Aston JL, Lodolce AE, Shapiro NL. Interaction between warfarin and cranberry juice. Pharmacotherapy. 2006;26:1314\u20131319.", "ArticleIdList": ["16945054"]}, {"Citation": "Rietjens IM, Martena MJ, Boersma MG, Spiegelenberg W, Alink GM. Molecular mechanisms of toxicity of important food-borne phytotoxins. Mol. Nutr. Food Res. 2005;49:131\u2013158.", "ArticleIdList": ["15635687"]}, {"Citation": "Cote CS, Kor C, Cohen J, Auclair K. Composition and biological activity of traditional and commercial kava extracts. Biochem. Biophys. Res. Commun. 2004;322:147\u2013152.", "ArticleIdList": ["15313185"]}, {"Citation": "Singh YN, Singh NN. Therapeutic potential of kava in the treatment of anxiety disorders. CNS Drugs. 2002;16:731\u2013743.", "ArticleIdList": ["12383029"]}, {"Citation": "Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Riggins C, Rister R. Kava Kava. In: Blumenthal M, editor. The Complete German Commission E Monographs. American Botanical Council; Austin, Texas: 1998. pp. 156\u2013157."}, {"Citation": "Johnson BM, Qiu SX, Zhang S, Zhang F, Burdette JE, Yu L, Bolton JL, van Breemen RB. Identification of novel electrophilic metabolites of piper methysticum Forst (Kava) Chem. Res. Toxicol. 2003;16:733\u2013740.", "ArticleIdList": ["12807356"]}, {"Citation": "Furbee RB, Barlotta KS, Allen MK, Holstege CP. Hepatotoxicity associated with herbal products. Clin. Lab. Med. 2006;26:227\u2013241.", "ArticleIdList": ["16567233"]}, {"Citation": "Whitton PA, Lau A, Salisbury A, Whitehouse J, Evans CS. Kava lactones and the kava-kava controversy. Phytochemistry. 2003;64:673\u2013679.", "ArticleIdList": ["13679089"]}, {"Citation": "Weiss J, Sauer A, Frank A, Unger M. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro. Drug Metab. Dispos. 2005;33:1580\u20131583.", "ArticleIdList": ["16051732"]}, {"Citation": "Wu D, Yu L, Nair MG, DeWitt DL, Ramsewak RS. Cyclooxygenase enzyme inhibitory compounds with antioxidant activities from Piper methysticum (kava kava) roots. Phytomedicine. 2002;9:41\u201347.", "ArticleIdList": ["11924763"]}, {"Citation": "Unger M, Holzgrabe U, Jacobsen W, Cummins C, Benet LZ. Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava-Kava) Planta Med. 2002;68:1055\u20131058.", "ArticleIdList": ["12494328"]}, {"Citation": "Mathews JM, Etheridge AS, Black SR. Inhibition of human cytochrome P450 activities by kava extract and kavalactones. Drug Metab. Dispos. 2002;30:1153\u20131157.", "ArticleIdList": ["12386118"]}, {"Citation": "Strahl S, Ehret V, Dahm HH, Maier KP. Necrotic hepatitis after intake of botanical dietary supplements. Dtsch. Med. Wochenschr. 1998;123:1410\u20131414.", "ArticleIdList": ["9856112"]}, {"Citation": "Unger M, Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun. Mass Spectrom. 2004;18:2273\u20132281.", "ArticleIdList": ["15384148"]}, {"Citation": "Haensel R, Sticher O, Steinegger E. Anthranoide. In: Haensel R, editor. Pharmacognosy - Phytopharmacy. Springer-Verlag; Berlin Heidelberg, Germany: 1999. pp. 890\u2013920."}, {"Citation": "Srinivas G, Babykutty S, Sathiadevan P, Srinivas P. Molecular Mechanism of Emodin Action: Transition from Laxative Ingredient to an Antitumor Agent. Med. Res. Rev. Epub. 2006:1\u201318.", "ArticleIdList": ["17019678"]}, {"Citation": "Masuda T, Ueno Y. Microsomal transformation of emodin into a direct mutagen. Mutat. Res. 1984;125:135\u2013144.", "ArticleIdList": ["6366529"]}, {"Citation": "Masuda T, Haraikawa K, Morooka N, Nakano S, Ueno Y. 2-Hydroxyemodin, an active metabolite of emodin in the hepatic microsomes of rats. Mutat. Res. 1985;149:327\u2013332.", "ArticleIdList": ["3887143"]}, {"Citation": "Morita H, Umeda M, Masuda T, Ueno Y. Cytotoxic and mutagenic effects of emodin on cultured mouse carcinoma FM3A cells. Mutat. Res. 1988;204:329\u2013332.", "ArticleIdList": ["3343982"]}, {"Citation": "Murakami H, Kobayashi J, Masuda T, Morooka N, Ueno Y. omega-Hydroxyemodin, a major hepatic metabolite of emodin in various animals and its mutagenic activity. Mutat. Res. 1987;180:147\u2013153.", "ArticleIdList": ["3309636"]}, {"Citation": "Akuzawa S, Yamaguchi H, Masuda T, Ueno Y. Radical-mediated modification of deoxyguanine and deoxyribose by luteoskyrin and related anthraquinones. Mutat. Res. 1992;266:63\u201369.", "ArticleIdList": ["1373839"]}, {"Citation": "Krivobok S, Seigle-Murandi F, Steiman R, Marzin DR, Betina V. Mutagenicity of substituted anthraquinones in the Ames/Salmonella microsome system. Mutat. Res. 1992;279:1\u20138.", "ArticleIdList": ["1374527"]}, {"Citation": "Zhang YP, Sussman N, Macina OT, Rosenkranz HS, Klopman G. Prediction of the carcinogenicity of a second group of organic chemicals undergoing carcinogenicity testing. Environ. Health Perspect. 1996;104(Suppl 5):1045\u20131050.", "ArticleIdList": ["PMC1469705", "8933053"]}, {"Citation": "Huang HC, Chang JH, Tung SF, Wu RT, Foegh ML, Chu SH. Immunosuppressive effect of emodin, a free radical generator. Eur. J. Pharmacol. 1992;211:359\u2013364.", "ArticleIdList": ["1535596"]}, {"Citation": "Rahimipour S, Bilkis I, Peron V, Gescheidt G, Barbosa F, Mazur Y, Koch Y, Weiner L, Fridkin M. Generation of free radicals by emodic acid and its [D-Lys6]GnRH-conjugate. Photochem. Photobiol. 2001;74:226\u2013236.", "ArticleIdList": ["11547560"]}, {"Citation": "Mueller SO, Eckert I, Lutz WK, Stopper H. Genotoxicity of the laxative drug components emodin, aloe-emodin and danthron in mammalian cells: topoisomerase II mediated? Mutat. Res. 1996;371:165\u2013173.", "ArticleIdList": ["9008718"]}, {"Citation": "Mueller SO, Lutz WK, Stopper H. Factors affecting the genotoxic potency ranking of natural anthraquinones in mammalian cell culture systems. Mutat. Res. 1998;414:125\u2013129.", "ArticleIdList": ["9630566"]}, {"Citation": "Mueller SO, Stopper H. Characterization of the genotoxicity of anthraquinones in mammalian cells. Biochim. Biophys. Acta. 1999;1428:406\u2013414.", "ArticleIdList": ["10434060"]}, {"Citation": "Bolton JL, Trush MA, Penning TM, Dryhurst G, Monks TJ. Role of quinones in toxicology. Chem. Res. Toxicol. 2000;13:135\u2013160.", "ArticleIdList": ["10725110"]}, {"Citation": "Levay G, Pongracz K, Bodell WJ. Detection of DNA adducts in HL-60 cells treated with hydroquinone and p-benzoquinone by 32P-postlabeling. Carcinogenesis. 1991;12:1181\u20131186.", "ArticleIdList": ["2070482"]}, {"Citation": "Su YT, Chang HL, Shyue SK, Hsu SL. Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signaling pathway. Biochem. Pharmacol. 2005;70:229\u2013241.", "ArticleIdList": ["15941563"]}, {"Citation": "National Toxicology Program NTP Toxicology and Carcinogenesis Studies of EMODIN (CAS No. 518-82-1) Feed studies in F344/N Rats and B6C3F1 Mice. Natl. Toxicol. Program Tech. Rep. Ser. 2001;493:1\u2013278.", "ArticleIdList": ["12563347"]}, {"Citation": "Brusick D, Mengs U. Assessment of the genotoxic risk from laxative senna products. Environ. Mol. Mutagen. 1997;29:1\u20139.", "ArticleIdList": ["9020301"]}, {"Citation": "Gunby P. Plant known for centuries still causes problems today. JAMA. 1979;241:2246\u20132247.", "ArticleIdList": ["439284"]}, {"Citation": "Anderson IB, Mullen WH, Meeker JE, Khojasteh Bakht SC, Oishi S, Nelson SD, Blanc PD. Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature. Ann. Intern. Med. 1996;124:726\u2013734. see comment.", "ArticleIdList": ["8633832"]}, {"Citation": "Chen LJ, Lebetkin EH, Burka LT. Metabolism of (R)-(+)-menthofuran in Fischer-344 rats: identification of sulfonic acid metabolites. Drug Metab. Dispos. 2003;31:1208\u20131213.", "ArticleIdList": ["12975329"]}, {"Citation": "Chen LJ, Lebetkin EH, Burka LT. Metabolism of (R)-(+)-pulegone in F344 rats. Drug Metab. Dispos. 2001;29:1567\u20131577.", "ArticleIdList": ["11717176"]}, {"Citation": "Bakerink JA, Gospe SM, Jr., Dimand RJ, Eldridge MW. Multiple organ failure after ingestion of pennyroyal oil from herbal tea in two infants. Pediatrics. 1996;98:944\u2013947.", "ArticleIdList": ["8909490"]}, {"Citation": "Khojasteh-Bakht SC, Nelson SD, Atkins WM. Glutathione S-transferase catalyzes the isomerization of (R)-2-hydroxymenthofuran to mintlactones. Arch. Biochem. Biophys. 1999;370:59\u201365.", "ArticleIdList": ["10496977"]}, {"Citation": "Thomassen D, Slattery JT, Nelson SD. Menthofuran-dependent and independent aspects of pulegone hepatotoxicity: roles of glutathione. J. Pharmacol. Exp. Ther. 1990;253:567\u2013572.", "ArticleIdList": ["2338648"]}, {"Citation": "Gordon WP, Huitric AC, Seth CL, McClanahan RH, Nelson SD. The metabolism of the abortifacient terpene, (R)-(+-) pulegone, to a proximate toxin, menthofuran. Drug Metab. Dispos. 1987;15:589\u2013594.", "ArticleIdList": ["2891472"]}, {"Citation": "Sztajnkrycer MD, Otten EJ, Bond GR, Lindsell CJ, Goetz RJ. Mitigation of pennyroyal oil hepatotoxicity in the mouse. Acad. Emerg. Med. 2003;10:1024\u20131028.", "ArticleIdList": ["14525732"]}, {"Citation": "Madyastha KM, Moorthy B. Pulegone mediated hepatotoxicity: evidence for covalent binding of R(+)-[14C]pulegone to microsomal proteins in vitro. Chem. Biol. Interact. 1989;72:325\u2013333.", "ArticleIdList": ["2691105"]}, {"Citation": "McClanahan RH, Thomassen D, Slattery JT, Nelson SD. Metabolic activation of (R)-(+-) pulegone to a reactive enonal that covalently binds to mouse liver proteins. Chem. Res. Toxicol. 1989;2:349\u2013355.", "ArticleIdList": ["2519826"]}, {"Citation": "Johnson BM, Bolton JL, van Breemen RB. Screening botanical extracts for quinoid metabolites. Chem. Res. Toxicol. 2001;14:1546\u20131551.", "ArticleIdList": ["11712913"]}, {"Citation": "Fennell TR, Miller JA, Miller EC. Characterization of the biliary and urinary glutathione and N-acetylcysteine metabolites of the hepatic carcinogen 1\u2032-hydroxysafrole and its 1\u2032-oxo metabolite in rats and mice. Cancer Res. 1984;44:3231\u20133240.", "ArticleIdList": ["6744260"]}, {"Citation": "Heikes DL. SFE with GC and MS determination of safrole and related allylbenzenes in sassafras teas. J. Chromatogr. Sci. 1994;32:253\u2013258.", "ArticleIdList": ["8063885"]}, {"Citation": "Bolton JL, Acay NM, Vukomanovic V. Evidence that 4-allyl-o-quinones spontaneously rearrange to their more electrophilic quinone methides: potential bioactivation mechanism for the hepatocarcinogen safrole. Chem. Res. Toxicol. 1994;7:443\u2013450.", "ArticleIdList": ["8075378"]}, {"Citation": "Miller EC, Swanson AB, Phillips DH, Fletcher TL, Liem A, Miller JA. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole. Cancer Res. 1983;43:1124\u20131134.", "ArticleIdList": ["6825084"]}, {"Citation": "Miller EC, Miller JA, Boberg EW, Delclos KB, Lai CC, Fennell TR, Wiseman RW, Liem A. Sulfuric acid esters as ultimate electrophilic and carcinogenic metabolites of some alkenylbenzenes and aromatic amines in mouse liver. Carcinog. Compr. Surv. 1985;10:93\u2013107.", "ArticleIdList": ["3904999"]}, {"Citation": "Boberg EW, Miller EC, Miller JA, Poland A, Liem A. Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1\u2032-sulfooxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1\u2032-hydroxysafrole in mouse liver. Cancer Res. 1983;43:5163\u20135173.", "ArticleIdList": ["6577945"]}, {"Citation": "Daimon H, Sawada S, Asakura S, Sagami F. Inhibition of sulfotransferase affecting in vivo genotoxicity and DNA adducts induced by safrole in rat liver. Teratog., Carcinog. Mutagen. 1997;17:327\u2013337.", "ArticleIdList": ["9485541"]}, {"Citation": "Jeng JH, Wang YJ, Chang WH, Wu HL, Li CH, Uang BJ, Kang JJ, Lee JJ, Hahn LJ, Lin BR, Chang MC. Reactive oxygen species are crucial for hydroxychavicol toxicity toward KB epithelial cells. Cell. Mol. Life Sci. 2004;61:83\u201396.", "ArticleIdList": ["14704856"]}, {"Citation": "Luo G, Guenthner TM. Covalent binding to DNA in vitro of 2\u2032,3\u2032-oxides derived from allylbenzene analogs. Drug Metab. Dispos. 1996;24:1020\u20131027. erratum appears in Drug Metab Dispos 1997 Jan;25(1):131.", "ArticleIdList": ["8886614"]}, {"Citation": "Gupta KP, van Golen KL, Putman KL, Randerath K. Formation and persistence of safrole-DNA adducts over a 10,000-fold dose range in mouse liver. Carcinogenesis. 1993;14:1517\u20131521.", "ArticleIdList": ["8102595"]}, {"Citation": "Randerath K, Putman KL, Randerath E. Flavor constituents in cola drinks induce hepatic DNA adducts in adult and fetal mice. Biochem. Biophys. Res. Commun. 1993;192:61\u201368.", "ArticleIdList": ["8476434"]}, {"Citation": "Daimon H, Sawada S, Asakura S, Sagami F. In vivo genotoxicity and DNA adduct levels in the liver of rats treated with safrole. Carcinogenesis. 1998;19:141\u2013146.", "ArticleIdList": ["9472705"]}, {"Citation": "Daimon H, Sawada S, Asakura S, Sagami F. Analysis of cytogenetic effects and DNA adduct formation induced by safrole in Chinese hamster lung cells. Teratog., Carcinog. Mutagen. 1997;17:7\u201318.", "ArticleIdList": ["9249926"]}, {"Citation": "Arlt VM, Stiborova M, Schmeiser HH. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis. 2002;17:265\u2013277.", "ArticleIdList": ["12110620"]}, {"Citation": "Kessler DA. Cancer and herbs. N. Engl. J. Med. 2000;342:1742\u20131743. [see comment][comment]", "ArticleIdList": ["10841878"]}, {"Citation": "Stiborova M, Frei E, Hodek P, Wiessler M, Schmeiser HH. Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH:cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer. Int. J. Cancer. 2005;113:189\u2013197.", "ArticleIdList": ["15386410"]}, {"Citation": "Greensfelder L. Infectious diseases. Polio outbreak raises questions about vaccine. Science. 2000;290:1867\u20131869.", "ArticleIdList": ["11187033"]}, {"Citation": "FDA . Letter to Health Professionals Regarding Safety Concerns Related to the Use of Botanical Products Containing Aristolochic Acid. Apr 4th, 2001."}, {"Citation": "Stiborova M, Hajek M, Frei E, Schmeiser HH. Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH: cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy. Gen. Physiol. Biophys. 2001;20:375\u2013392.", "ArticleIdList": ["11989648"]}, {"Citation": "Stiborova M, Frei E, Wiessler M, Schmeiser HH. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2. Chem. Res. Toxicol. 2001;14:1128\u20131137.", "ArticleIdList": ["11511187"]}, {"Citation": "Stiborova M, Frei E, Sopko B, Wiessler M, Schmeiser HH. Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy. Carcinogenesis. 2002;23:617\u2013625.", "ArticleIdList": ["11960915"]}, {"Citation": "Arlt VM, Glatt H, Muckel E, Pabel U, Sorg BL, Seidel A, Frank H, Schmeiser HH, Phillips DH. Activation of 3-nitrobenzanthrone and its metabolites by human acetyltransferases, sulfotransferases and cytochrome P450 expressed in Chinese hamster V79 cells. Int. J. Cancer. 2003;105:583\u2013592.", "ArticleIdList": ["12740904"]}, {"Citation": "Pfau W, Schmeiser HH, Wiessler M. Aristolochic acid binds covalently to the exocyclic amino group of purine nucleotides in DNA. Carcinogenesis. 1990;11:313\u2013319.", "ArticleIdList": ["2302759"]}, {"Citation": "Stiborova M, Frei E, Breuer A, Wiessler M, Schmeiser HH. Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthase -- (32)P-postlabeling analysis of DNA adduct formation. Mutat. Res. 2001;493:149\u2013160.", "ArticleIdList": ["11516724"]}, {"Citation": "Schmeiser HH, Janssen JW, Lyons J, Scherf HR, Pfau W, Buchmann A, Bartram CR, Wiessler M. Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues. Cancer Res. 1990;50:5464\u20135469.", "ArticleIdList": ["2201437"]}, {"Citation": "IARC . Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. IARC; Lyon: 2002. 2002.", "ArticleIdList": ["PMC4781602", "12687954"]}, {"Citation": "Scientific, C.o.t.E.F.S.A  . Discussion paper on botanicals and botanical preparations widely used as food supplements and related products: coherent and comprehensive risk assessment and consumer information approaches. Brussel; 2004. pp. 1\u20136.  http://www.efsa.eu.int/science/sc_commitee/sc_documents/616/scdoc_advice03_botanicals_en1.pdf."}]}], "History": [{"Year": "2007", "Month": "3", "Day": "17", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "8", "Day": "10", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "3", "Day": "17", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "8", "Day": "8"}], "PublicationStatus": "ppublish", "ArticleIdList": ["17362034", "NIHMS58216", "PMC2504026", "10.1021/tx7000527"]}}], "PubmedBookArticle": []}